TRANSKARYOTIC THERAPIES INC 4
4 · TRANSKARYOTIC THERAPIES INC · Filed Jul 29, 2005
Insider Transaction Report
Form 4
Pauwels Eric
Sr. VP- Global Commercial Ops
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2005-07-27$9.26/sh−100,000$926,000→ 0 totalExercise: $27.74Exp: 2015-04-13→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option, which was granted on April 13, 2005 and provided for vesting in five equal annual installments beginning on April 13, 2006, was cancelled pursuant to a merger agreement among the Issuer, Shire Pharmaceuticals Group plc and Sparta Acquisition Corporation, dated April 21, 2005, in exchange for a cash payment of $926,000, representing the excess of $37.00 over the per share exercise price of the option multiplied by the number of shares subject to the option, whether vested or unvested.